Matches in Wikidata for { <http://www.wikidata.org/entity/Q37692849> ?p ?o ?g. }
- Q37692849 description "article científic" @default.
- Q37692849 description "article scientifique" @default.
- Q37692849 description "articolo scientifico" @default.
- Q37692849 description "artigo científico" @default.
- Q37692849 description "artículu científicu espublizáu en 2014" @default.
- Q37692849 description "bilimsel makale" @default.
- Q37692849 description "scientific article published on March 2014" @default.
- Q37692849 description "vedecký článok" @default.
- Q37692849 description "vetenskaplig artikel" @default.
- Q37692849 description "videnskabelig artikel" @default.
- Q37692849 description "vědecký článek" @default.
- Q37692849 description "wetenschappelijk artikel" @default.
- Q37692849 description "wissenschaftlicher Artikel" @default.
- Q37692849 description "наукова стаття, опублікована в березні 2014" @default.
- Q37692849 description "научни чланак" @default.
- Q37692849 description "مقالة علمية نشرت في مارس 2014" @default.
- Q37692849 name "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 name "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 name "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 type Item @default.
- Q37692849 label "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 label "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 label "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 prefLabel "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 prefLabel "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 prefLabel "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 P1433 Q37692849-5F120921-2C5A-45DD-8779-49920DA8D43F @default.
- Q37692849 P1476 Q37692849-9CAD72EB-C5C9-4166-955C-F80C626EEA54 @default.
- Q37692849 P2093 Q37692849-7A99D09D-255B-466B-9C4C-B58A15C728DB @default.
- Q37692849 P2093 Q37692849-B65FA393-C960-429C-8B01-BDF149B8415F @default.
- Q37692849 P275 Q37692849-efe55406-6202-4d7c-b0db-69dda8581bf5 @default.
- Q37692849 P2860 Q37692849-04E4B39C-E0E7-46B2-A9B3-A1E167CDEE0D @default.
- Q37692849 P2860 Q37692849-07EEAE3D-395F-4247-953F-16EADB8F5261 @default.
- Q37692849 P2860 Q37692849-131B653B-F8BB-4243-AB34-2E07051AC246 @default.
- Q37692849 P2860 Q37692849-17F8EB83-6DC4-4AB7-8CA2-35E854ACA8F6 @default.
- Q37692849 P2860 Q37692849-19FC3E0A-00DC-42E3-B983-4339FB2C1F47 @default.
- Q37692849 P2860 Q37692849-1A9F61CF-31DC-419B-88C4-26AD00951E67 @default.
- Q37692849 P2860 Q37692849-1DC31AFB-8334-493A-A4DC-6C35FF48B319 @default.
- Q37692849 P2860 Q37692849-23A61B0A-01AA-4FED-9D34-4A2BF981C616 @default.
- Q37692849 P2860 Q37692849-2961CFA5-190C-4FC9-A564-0DDED6B0B6FA @default.
- Q37692849 P2860 Q37692849-3AF27970-F303-4AED-B5F5-25220F25FAC7 @default.
- Q37692849 P2860 Q37692849-3E5778BD-99AB-41EE-A77E-3102641C3794 @default.
- Q37692849 P2860 Q37692849-451226B8-6F92-4158-92CC-45FB79DCA280 @default.
- Q37692849 P2860 Q37692849-481159B4-D846-4803-AD2C-3A4038CF3B94 @default.
- Q37692849 P2860 Q37692849-5E448822-3698-4CCB-ABE0-C8B2558023F6 @default.
- Q37692849 P2860 Q37692849-6A4AF36A-AF3D-4254-9208-DED830136607 @default.
- Q37692849 P2860 Q37692849-6C8342CC-B05B-47A9-9AF0-F431F50C32CE @default.
- Q37692849 P2860 Q37692849-70D79D2E-6114-4352-AAB4-6E3FB96BD46B @default.
- Q37692849 P2860 Q37692849-7242CA8D-9E25-43FC-8238-8C4272F2A011 @default.
- Q37692849 P2860 Q37692849-9D46B97E-CB32-4F7D-9087-EB795DED2E96 @default.
- Q37692849 P2860 Q37692849-A471FA52-885E-4E3F-AAE2-ECAA3CED714D @default.
- Q37692849 P2860 Q37692849-BA90CAC2-139F-4D7D-8ADC-91DFAAAF9204 @default.
- Q37692849 P2860 Q37692849-BD261F00-E9A2-427E-AC2C-C1E56A7B1CB4 @default.
- Q37692849 P2860 Q37692849-BE3F6E05-C522-448F-8684-0B3B1CA2BB8E @default.
- Q37692849 P2860 Q37692849-C8E40472-9345-433C-9144-2992AD29706E @default.
- Q37692849 P2860 Q37692849-CA56C63D-86A9-451B-B0A9-ABC02B22700A @default.
- Q37692849 P2860 Q37692849-D1D58180-3A47-4996-876C-35B7D3711EC6 @default.
- Q37692849 P2860 Q37692849-D2270868-E20F-43C2-885E-26F066349154 @default.
- Q37692849 P2860 Q37692849-E097144C-9DDA-4110-BB96-543D03C28CBD @default.
- Q37692849 P2860 Q37692849-E0FFE13C-B081-4F29-B305-2C11D27F2B97 @default.
- Q37692849 P2860 Q37692849-EAF057C1-FF97-48A4-BBA9-33AD0337C37C @default.
- Q37692849 P2860 Q37692849-F86926E3-556C-44F7-8177-25181326D908 @default.
- Q37692849 P2888 Q37692849-C326DFD9-F149-4B75-A02F-19A52B34CB45 @default.
- Q37692849 P304 Q37692849-17BE2903-80B9-4283-956D-D0E0C659EB5B @default.
- Q37692849 P31 Q37692849-00B018C4-8CCF-491F-BB44-0D4F65D7E140 @default.
- Q37692849 P356 Q37692849-94391831-DFB0-416A-B103-72B6F41AB995 @default.
- Q37692849 P433 Q37692849-BF1D1B08-6C9A-434C-8C86-229109C54055 @default.
- Q37692849 P478 Q37692849-E574EA09-BCB2-4391-9E90-0081A3BDF5EE @default.
- Q37692849 P50 Q37692849-9005825A-3019-445D-B10C-D62FB871B2E3 @default.
- Q37692849 P577 Q37692849-1A3237A8-DE85-4969-88A0-9958D6AB1213 @default.
- Q37692849 P5875 Q37692849-8DA421C1-6837-41E4-BCEB-6BC85F5DF6BA @default.
- Q37692849 P6216 Q37692849-acf8f9e7-050e-4135-9f47-fb5ef2c379af @default.
- Q37692849 P698 Q37692849-84BA1C25-AC43-4609-8ED4-12C2F671F8A5 @default.
- Q37692849 P921 Q37692849-4AE0EB7E-CB7A-41A8-A519-13626550CF6C @default.
- Q37692849 P921 Q37692849-5909619f-18a6-4891-8fd2-167fd8800443 @default.
- Q37692849 P921 Q37692849-6C1C7540-3695-477B-A783-975B6BF195B6 @default.
- Q37692849 P921 Q37692849-A106AD5D-5C7F-4BD7-AA13-D0AD122DBFEB @default.
- Q37692849 P921 Q37692849-BF62A3A2-8109-4FC3-83A2-28363CAB1C41 @default.
- Q37692849 P932 Q37692849-4F3487F2-3C98-431E-9602-946550E45612 @default.
- Q37692849 P356 S00125-014-3196-X @default.
- Q37692849 P698 24585202 @default.
- Q37692849 P1433 Q5270140 @default.
- Q37692849 P1476 "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" @default.
- Q37692849 P2093 "Andrea Mari" @default.
- Q37692849 P2093 "David Polidori" @default.
- Q37692849 P275 Q20007257 @default.
- Q37692849 P2860 Q22241288 @default.
- Q37692849 P2860 Q28732080 @default.
- Q37692849 P2860 Q29417144 @default.
- Q37692849 P2860 Q31137356 @default.
- Q37692849 P2860 Q34227891 @default.
- Q37692849 P2860 Q34363859 @default.
- Q37692849 P2860 Q34646948 @default.
- Q37692849 P2860 Q34804900 @default.
- Q37692849 P2860 Q36845771 @default.
- Q37692849 P2860 Q36997767 @default.
- Q37692849 P2860 Q37022726 @default.
- Q37692849 P2860 Q37106527 @default.
- Q37692849 P2860 Q37286297 @default.
- Q37692849 P2860 Q37302078 @default.